Yes multiples change but the point here is that the quoted multiple of 10X revenue is 250% of the average biotech multiple. It doesn't matter if the multiple trend changes over time if the suggested multiple remains 250% of the current average or whatever the average will be in future itwill call into question whether its reasonable.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.